Divis Laboratories Ltd | DIVI - Le Bénéfice D'Exploitation

Prix De L'Action
6,100.00
Variation Quotidienne
127.50 2.13%
Mensuellement
-3.07%
Annuel
5.22%
Q1 Prévisions
5,976.17




Le Bénéfice D'Exploitation Changement Date
Alaunos Therapeutics USD -1.19M 148K 2025-09
Aurobindo Pharma INR 13.09B 597M 2025-12
Avita Medical AUD -10.41M 742K 2025-12
Dianthus Therapeutics USD -69.54M 29.25M 2025-12
Divis Laboratories Ltd INR 7.72B 30M 2025-12
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Lupin INR 18.97B 757M 2025-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 62M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -21.52M 374K 2025-12
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 16.77M 10.04M 2025-12